Phil Nadeau, an analyst from TD Cowen, maintained the Buy rating on Vertex Pharmaceuticals (VRTX – Research Report). The associated price ...

The challenging conditions of the plateau, with its harsh climate and environment, require PV modules to deliver exceptional ...

Vertex Pharmaceuticals again raised its full-year outlook after posting earnings and revenue growth in the third quarter. The biotechnology company on Monday posted a quarterly net profit of $1.05 ...

Vertex also reported a steady increase in its R&D and SG&A expenses, reflecting its aggressive investment in pipeline ...

Trina Solar says it has supplied more than 1 GW of Vertex N 720W series panels for the Jinsha River project in China, with ...

In its upcoming report, Vertex Pharmaceuticals (VRTX ... trends in earnings estimate revisions and the short-term price performance of a stock. While investors typically use consensus earnings ...

Trinasolar, a global leader in smart photovoltaic (PV) and energy storage solutions has joined forces with Kiwi Solar and ...

Crispr Therapeutics recently received FDA and EMA approval for Casgevy. Read why CRSP stock is compelling investment in the ...

Vertex Pharmaceuticals Inc. (VRTX) released a profit for its third quarter that increased from the same period last year and beat ...

This partnership will bring together the multimodality and natural language capabilities of Gemini on Vertex AI – Google ...

Honeywell and Google Cloud announced a unique collaboration connecting artificial intelligence (AI) agents with assets, ...